Zusammenfassung
Pathologische Gefäßveränderungen (AIDS-assoziierte Vaskulopathie), insbesondere das Kaposi-Sarkom (KS), stellen wesentliche klinische Ausprägungen der AIDS-Erkrankung dar. Im Rahmen dieser Arbeit konnte anhand von in vivo-Untersuchungen eine Beteiligung von vascular endothelial cell growth factor (VEGF) bei der AIDS-assoziierten Vaskulopathie belegt werden. Darüberhinaus konnte die Rolle eines neu entdeckten humanen Herpesvirus, HHV-8, in der KS-Entwicklung eingegrenzt werden. In situ-Untersuchungen zur HHV-8-Genexpression in KS-Biopsien deuten darauf hin, daß dieses Virus vor allem die KS-Progression und weniger die Initiation beeinflußt. Hierbei könnte ein Viruskodiertes Cyclin D-homologes Protein, welches in latent infizierten KS-Spindelzellen exprimiert wird, einen wichtigen Progressionsfaktor darstellen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aboulafìa D, Miles SA, Saks SR, Mitsuyasu RT (1989) Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi’s sarcoma. J Acquir Immune Defic Syndr 2: 54–58
Albrecht H, Stellbrink HJ, Gross G, Berg B, Helmchen U, Mensing H (1994) Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi’s sarcoma in an AIDS patient. Clin Investig 72: 1041–1047
Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 268: 582–583
Ascherl G, Hohenadl C, Schatz O, Schumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M (1999) Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T-cells: implications for acquired immunodeficiency syndrome- associated vasculopathy. Blood 93: 1–11
Ballard HS (1985) Disseminated Kaposi’s sarcoma without lymphocyte abnormalities. Arch Intern Med 145: 547
Beckstead JH (1992) Oral presentation of Kaposi’s sarcoma in a patient without severe immunodeficiency. Arch Pathol Lab Med 116: 543–545
Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Stürzl M (1997) Monocytes in Kaposi’ls sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71: 7963–7968
Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G (1996) Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi’s sarcoma ( KS) biopsies. Int J Cancer 65: 25–28
Caruso A, Gonzales R, Stellini R, Scalzini A, Peroni L, Turano A (1990) Interferon-gamma marks activated T lymphocytes in AIDS patients. AIDS Res Hum Retroviruses 6: 899–904
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpes- virus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191
Cesarman E, Knowles DM (1997) Kaposi’s sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Semin Diagn Pathol 14:54’66
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869
Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Stürzl M (1996) Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi’s sarcoma. Am J Pathol 149: 18513–1869
Davis MA, Stürzl M, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ (1997) Expression of human herpesvirus 8-encoded cyclin D in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst 89: 1868–1874
De Paoli P, Caffau C, M DA, Tavio M, Tirelli U, Santini G (1994) Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi’s sarcoma. J Acquir Immune Defic Syndr 7: 695–699
Ensoli B, Stürzl M (1998) Kaposi’s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9: 63–83
Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375–2378
Fan J, Bass HZ, Fahey JL (1993) Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 151: 5031–5040
Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B (1995) Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS- Kaposi’s sarcoma spindle cells. J Clin Invest 95: 1723–1734
Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 2: 925–928
Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A (1989) Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol 78: 329–333
Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE (1995) Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma. Lancet 345: 759–761
Kalinkovich A, Livshits G, Engelmann H, Harpaz N, Burstein R, Kaminsky M, Wallach D, Bentwich Z (1993) Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes. Clin Exp Immunol 93: 350–355
Kestens L, Melbye M, Biggar RJ, Stevens WJ, Piot P, De Muynck A, Taelman H, De Feyter M, Paluku L, Gigase PL (1985) Endemic African Kaposi’s sarcoma is not associated with immunodeficiency. Int J Cancer 36: 49–54
Krigel RL, Odajnyk CM, Laubenstein LJ, Ostreicher R, Wernz J, Vilcek J, Rubinstein P, Friedman- Kien AE (1985) Therapeutic trial of interferon-gamma in patients with epidemic Kaposi’s sarcoma. J Biol Response Mod 4: 358–364
Lähdevirta J, Maury CP, Teppo AM, Repo H (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85: 289–291
Lepe-Zuniga JL, Mansell PW, Hersh EM (1987) Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol 25: 1695–1700
Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR (1992) Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 166: 253–259
Master SP, Taylor JF, Kyalwazi SK, Ziegler JL (1970) Immunological studies in Kaposi’s sarcoma in Uganda. Br Med J 1: 600–602
Maurice PD, Smith NP, Pinching AJ (1982) Kaposi’s sarcoma with benign course in a homosexual. Lancet 1: 571
Neipel F, Albrecht JC, Fleckenstein B (1997) Cell-homologous genes in the Kaposi’s sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71: 4187–4192
Rizzardini G, Piconi S, Ruzzante S, Fusi ML, Lukwiya M, Declich S, Tamburini M, Villa ML, Fabiani M, Milazzo F, Clerici M (1996) Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. Aids 10: 1535–1542
Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93: 14862–14867
Samaniego F, Markham PD, Gallo RC, Ensoli B (1995) Inflammatory cytokines induce AIDS-Kaposi–s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J Immunol 154: 3582–3592
Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P (1995) A role for a new herpes virus ( KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1: 707–708
Schlesinger M, Chu FN, Badamchian M, Jiang JD, Roboz JP, Goldstein AL, Bekesi JG (1994) A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals. Clin Immunol Immunopathol 73: 252–260
Sciacca FL, Stürzl M, Bussolino F, Sironi M, Brandstetter H, Zietz C, Zhou D, Matteucci C, Peri G, Sozzani S, et al. (1994) Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi’s sarcoma cells. J Immunol 153: 4816–4825
Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S, Angeloni A, Faggioni A, Cerimele D, Cottoni F, Aiuti F, Ensoli B (1998) gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi’s sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesionai macrophages. Blood 91: 968–976
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay MF, Clauvel JP, Raphael M, Degos L, et al. (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86: 1276–1280
Stürzl M, Ascherl G, Blasig C, Opalenik SR, Ensoli B, Browning PJ (1998) Expression of the human herpesvirus 8-encoded viral macrophage inflammatory protein-1 gene in Kaposi’s sarcoma lesions. Aids 12: 1105–1106
Stürzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M, Kaaya EE, Tschachler E, Biberfeld P (1997) Expression of HHV-8 latency-associated To.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi’s sarcoma. Int J Cancer 72: 68–71
Stürzl M, Brandstetter H, Zietz C, Eisenburg B, Raivich G, Gearing DP, Brockmeyer NH, Hofschneider PH (1995) Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi’s sarcoma: a combined in vitro and in vivo analysis. Oncogene 10: 2007–2016
Stürzl M, Ensoli B (1999) Big but weak: how many pathogenic genes does human herpesvirus-8 need to cause Kaposi’s sarcoma? Int J Oncol 14: 287–289
Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH (1992) Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A 89: 7046–7050
Stürzl M, Wunderlich A, Ascherl G, Hohenadl C, Monini P, Zietz C, Browning PJ, Neipel F, Biberfeld P, Ensoli B (1999) Human herpesvirus-8 (HHV-8) gene expression in Kaposi’s sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia 13 (Suppl 1): S110–112
Vyakarnam A, Matear P, Meager A, Kelly G, Stanley B, Weller I, Beverley P (1991) Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol 84: 109–115
Yang J, Xu Y, Zhu C, Hagan MK, Lawley T, Offermann MK (1994) Regulation of adhesion molecule expression in Kaposi’s sarcoma cells. J Immunol 152: 361–373
Zietz C, Hotz B, Stürzl M, Rauch E, Penning R, Lohrs U (1996) Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am J Pathol 149: 1887–1898
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stürzl, M., Ascherl, G., Tschachler, E., Monini, P., Ensoli, B., Hohenadl, C. (2000). Angiogene Wachstumsfaktoren und humanes Herpesvirus-8: Schlüsselregulatoren der AIDS-assoziierten Vaskulopathie. In: Brockmeyer, N.H., Hoffmann, K., Reimann, G., Stücker, M., Altmeyer, P., Brodt, R. (eds) HIV-Infekt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59683-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-59683-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64082-7
Online ISBN: 978-3-642-59683-4
eBook Packages: Springer Book Archive